DC2 — Pro-resolving mechanisms in rheumatoid arthritis-associated cardiovascular disease

DC2 — Pro-resolving mechanisms in rheumatoid arthritis-associated cardiovascular disease
DC2
Status: Closed
Supervisor
Professor Catherine Godson
Host Institution
University College Dublin
City
Dublin
Country
Ireland

About this Project

This project will identify resolution pathways that become dysregulated when rheumatoid arthritis is complicated by diabetes, hypertension or cardiovascular disease. It will evaluate the vascular and cardioprotective actions of resoloxins using animal models, human vascular organoids and patient-derived tissues.

Your profile and what you'll gain

Skills required

Background in pharmacology, immunology, cardiovascular biology or biomedical science; experience with cell culture or experimental disease models; interest in translational vascular research.

Skills acquired

Cardiovascular disease models, single-cell RNA sequencing, human induced-pluripotent-stem-cell-derived vascular organoids, plaque explant studies, transcriptomics, proteomics, lipidomics and therapeutic-response assessment.

Eligibility Criteria

Before applying, candidates should ensure they meet the following eligibility criteria:

  • have a MSc degree in Life Sciences or obtain a MSc degree by October 2026
  • have completed a research internship with relevant expertise
  • have obtained high grades during his/her studies
  • be fluent in English (some countries may also require language certifications – this will be communicated to applicants following shortlisting)
  • applicant must not have resided in the country of the recruiting organisation for more than 12 months preceding the recruitment date. 
Supervisor
Professor Catherine Godson
• Closed
Host Institution
University College Dublin
City
Dublin
Country
Ireland

Applications closed

Applications closed on 1 October 2026 and are now under review.

Share this project

15 doctoral projects

Find the project that fits you

  • DC1
    • Closed

    Cellular mechanisms of inflammation resolution in rheumatoid arthritis

    Supervisor: Professor Gerhard Krönke
    Institution: Charité – Universitätsmedizin Berlin
  • DC3
    • Closed

    Why does inflammation resolve in some forms of arthritis but persist in others?

    Supervisor: Dr Marc Dubourdeau
    Institution: AMBIOTIS
  • DC4
    • Closed

    Cardiac-cell metabolism in inflammatory arthritis

    Supervisor: Professor Mauro Perretti
    Institution: Queen Mary University of London
  • DC5
    • Closed

    Specialised pro-resolving mediators in cardiometabolic disease: human population studies

    Supervisor: Dr Marleen van Greevenbroek
    Institution: Maastricht University
  • DC6
    • Closed

    Macrophage-fibroblast mechanisms restoring joint immune homeostasis

    Supervisor: Professor Mariola Kurowska-Stolarska
    Institution: University of Glasgow
  • DC7
    • Closed

    MCTR3 signalling in synovial inflammation and tissue repair

    Supervisor: Professor Jesmond Dalli
    Institution: Queen Mary University of London
  • DC8
    • Closed

    Role of canonical–atypical chemokine receptor axis in resolution of inflammation

    Supervisor: Professor Martine Smit
    Institution: Vrije Universiteit Amsterdam
  • DC9
    • Closed

    Redox control of inflammatory fibroblast priming

    Supervisor: Professor Markus Hoffmann
    Institution: University Hospital Schleswig-Holstein
  • DC10
    • Closed

    Macrophage-derived specialised pro-resolving mediators in hypertension and cardiovascular damage

    Supervisor: Professor Ana Maria Briones
    Institution: Universidad Autónoma de Madrid
  • DC11
    • Closed

    Computational identification of therapeutic checkpoints and resolution-promoting agents

    Supervisor: Professor Olaf Wolkenhauer
    Institution: University of Rostock
  • DC12
    • Closed

    Small-molecule promoters of inflammation resolution

    Supervisor: Professor Trond V. Hansen
    Institution: University of Oslo
  • DC13
    • Closed

    Lipid-mediator class-switching drugs

    Supervisor: Professor Oliver Werz
    Institution: Friedrich Schiller University Jena
  • DC14
    • Closed

    Resomelagon in rheumatoid arthritis and cardiovascular comorbidities

    Supervisor: Professor Mauro Perretti
    Institution: Queen Mary University of London
  • DC15
    • Closed

    Specialised pro-resolving mediators as regulators of haematopoiesis in rheumatoid arthritis and cardiovascular disease

    Supervisor: Professor Jesmond Dalli
    Institution: Queen Mary University of London